ResMed Inc. $RMD Shares Sold by Pacific Point Advisors LLC

Pacific Point Advisors LLC significantly reduced its stake in ResMed Inc. (NYSE:RMD) by 75.7% in Q4, selling 4,726 shares and retaining 1,515 shares valued at $365,000. Despite this sell-off, ResMed exceeded quarterly earnings and revenue estimates, prompting analysts to raise price targets, with the company currently holding a “Moderate Buy” consensus rating and a $299.27 target. Insider selling by the CEO and a director was also noted, although institutional ownership remains high at 54.98%.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin